JENNIFER MULLICAN: Open Payments
NPI 1497297386 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 49 payments from 14 companies in 2025. Trend: 2023 $304 · 2024 $520 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $335 |
| PFIZER INC. | 3 | $130 |
| Novo Nordisk Inc | 6 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
| ABBVIE INC. | 3 | $79 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Amgen Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: AIRSUPRA, NURTEC ODT, FARXIGA, Ozempic, Kerendia, QULIPTA, Cologuard Collection Kit, Wegovy.
Industry payments across TX — which companies pay providers there.
